Temasek backs Chinese biotech firm Innovent's $150m Series E

Temasek backs Chinese biotech firm Innovent's $150m Series E

Photo by Martin Lopez from Pexels

Deepshikha Monga

27 April, 2018

ally bridge groupCapital Group Private MarketsCormorant Asset ManagementHillhouse CapitalIncInnovent BiologicsLegend CapitalLilly Asia VenturesRock Springs CapitalTaikang InsuranceTemasek Holdings

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.